NO20072433L - Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel - Google Patents

Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel

Info

Publication number
NO20072433L
NO20072433L NO20072433A NO20072433A NO20072433L NO 20072433 L NO20072433 L NO 20072433L NO 20072433 A NO20072433 A NO 20072433A NO 20072433 A NO20072433 A NO 20072433A NO 20072433 L NO20072433 L NO 20072433L
Authority
NO
Norway
Prior art keywords
mequitazine
cyclodextrin
complex consisting
complex
interaction agent
Prior art date
Application number
NO20072433A
Other languages
English (en)
Norwegian (no)
Inventor
Hubert Lochard
Bernard Freiss
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NO20072433L publication Critical patent/NO20072433L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20072433A 2004-10-21 2007-05-11 Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel NO20072433L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0411202A FR2876910B1 (fr) 2004-10-21 2004-10-21 Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
PCT/EP2005/055388 WO2006042857A2 (fr) 2004-10-21 2005-10-19 Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction

Publications (1)

Publication Number Publication Date
NO20072433L true NO20072433L (no) 2007-05-11

Family

ID=34949969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072433A NO20072433L (no) 2004-10-21 2007-05-11 Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel

Country Status (18)

Country Link
US (1) US7749982B2 (pt)
EP (1) EP1802348A2 (pt)
JP (1) JP5157447B2 (pt)
KR (1) KR101273840B1 (pt)
CN (1) CN101043908B (pt)
AR (1) AR051593A1 (pt)
AU (1) AU2005296875B2 (pt)
BR (1) BRPI0516233A (pt)
CA (1) CA2583783C (pt)
FR (1) FR2876910B1 (pt)
IL (1) IL182412A (pt)
MX (1) MX2007004787A (pt)
NO (1) NO20072433L (pt)
NZ (1) NZ555238A (pt)
RU (1) RU2389491C2 (pt)
TW (1) TWI372759B (pt)
WO (1) WO2006042857A2 (pt)
ZA (1) ZA200703080B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
JP7029886B2 (ja) * 2017-04-28 2022-03-04 ロート製薬株式会社 医薬組成物及びその製造方法
KR20220085094A (ko) 2020-12-14 2022-06-22 메디케어제약 주식회사 알레르기성 결막염을 동반한 만성 비염을 치료하는 약제학적 복합제제

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1250534A (pt) 1969-03-03 1971-10-20
FR2522660A1 (fr) * 1982-03-05 1983-09-09 Pharmuka Lab Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
JP2735122B2 (ja) * 1988-06-13 1998-04-02 旭化成工業株式会社 メキタジンの液状シロップ製剤
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
KR920006911B1 (ko) * 1989-06-14 1992-08-22 신풍제약 주식회사 안정한 피록시캄 주사액 조성물 및 그의 제조방법
RU2097025C1 (ru) * 1990-11-06 1997-11-27 Ниппон Синяку Компани, Лимитед Лиофилизированный препарат жировой эмульсии и способ его получения
TW262497B (en) 1994-06-29 1995-11-11 Toshiba Co Ltd Washing machine
FR2742053B1 (fr) * 1995-12-06 1998-03-06 Chauvin Lab Sa Compositions pharmaceutiques a base de mequitazine
WO1998002186A1 (en) * 1996-07-11 1998-01-22 Farmarc Nederland B.V. Inclusion complex containing indole selective serotonin agonist
JPH10167954A (ja) * 1996-12-05 1998-06-23 Takada Seiyaku Kk メキタジン製剤
GB9800936D0 (en) 1997-05-10 1998-03-11 Univ Nottingham Biofunctional polymers
DE69911159T2 (de) * 1999-01-06 2004-06-24 Técnimede-Sociedade Técnico-Medicinal, S.A. Cyclodextrin Einschlusskomplexe mit Aminosäuresalzen von Benzimidazolderivaten, deren Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
FR2788436A1 (fr) * 1999-01-14 2000-07-21 Pf Medicament Composition d'un derive de phenothiazine
FR2815540B1 (fr) * 2000-10-19 2005-06-10 Separex Sa Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote
WO2002089851A1 (fr) * 2001-03-06 2002-11-14 Separex (Societe Anonyme) Procede de fabrication de complexes hote-client
FR2830761B1 (fr) 2001-10-12 2003-12-12 Pf Medicament Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique
FR2830760B1 (fr) 2001-10-12 2004-06-04 Pf Medicament Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique
FR2854079B1 (fr) 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
DK2260871T3 (da) 2004-04-01 2013-08-26 Pf Medicament Inklusionskomplekser omfattende piroxicam, en cyklodextrin og arginin

Also Published As

Publication number Publication date
BRPI0516233A (pt) 2008-08-26
WO2006042857A3 (fr) 2006-07-27
US20070293454A1 (en) 2007-12-20
JP2008517035A (ja) 2008-05-22
RU2007118640A (ru) 2008-11-27
CN101043908B (zh) 2011-11-16
FR2876910A1 (fr) 2006-04-28
IL182412A (en) 2015-02-26
KR20070084223A (ko) 2007-08-24
RU2389491C2 (ru) 2010-05-20
US7749982B2 (en) 2010-07-06
EP1802348A2 (fr) 2007-07-04
JP5157447B2 (ja) 2013-03-06
IL182412A0 (en) 2007-07-24
AU2005296875A1 (en) 2006-04-27
AR051593A1 (es) 2007-01-24
AU2005296875B2 (en) 2011-03-31
CN101043908A (zh) 2007-09-26
CA2583783C (fr) 2013-05-21
NZ555238A (en) 2010-04-30
CA2583783A1 (fr) 2006-04-27
FR2876910B1 (fr) 2007-04-13
KR101273840B1 (ko) 2013-06-11
ZA200703080B (en) 2008-05-28
WO2006042857A2 (fr) 2006-04-27
TW200621770A (en) 2006-07-01
TWI372759B (en) 2012-09-21
MX2007004787A (es) 2007-05-15

Similar Documents

Publication Publication Date Title
NO20080633L (no) Bis(tio-hydrazidamid)formulering
NO20091609L (no) Process for producing iron arsenide compound with good crystallinity
RU2013132210A (ru) Новая фармацевтическая композиция, включающая нпвс и циклодекстрин
EA200300354A1 (ru) Хинолиноновые производные в качестве ингибиторов тирозинкиназы
NO20072066L (no) Cyklodekstrininnlemmelseskomplekser og fremgangsmater ved fremstilling derav
UA92472C2 (ru) Фармацевтическая композиция, которая содержит 4-{4-[3-(4-хлор-3-трифторметилфенил)-уреидо]- 3-фторфенокси}-пиридин-2-карбоновой кислоты метиламид (варианты), способ получения твердой дисперсии указанного соединения и способ лечения с применением указанного соединения (варианты)
NO20054957L (no) Subtituerte karboksylsyrer
TW200718424A (en) Novel compounds of amino sulfonyl derivatives
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
MXPA05011150A (es) 2-hidroxi-3-diaminoalcanos de benzamida.
NO20064676L (no) Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre
TW200505418A (en) Phenacyl 2-hydroxy-3-diaminoalkanes
MY136686A (en) Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
MX2024001417A (es) Compuestos de heteroarilo para tratar la enfermedad de huntington.
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
PT1254146E (pt) Processos de preparacao de polimeros de claritromicina e novo polimorfo iv
DE60039878D1 (de) XENON ALS NMDA-ANTOGONIST zur Neuroprotektion
NO341574B1 (no) Forbindelse, farmasøytisk sammensetning og sett for behandling av cancer eller i en avbildningsmetode.
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
NO20072433L (no) Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
MX2024014435A (es) Compuestos heterociclicos y heteroarilo para el tratamiento de la enfermedad de huntington
TW200716547A (en) Piperidin-4-yl-amide derivatives
EP1817312A4 (en) MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application